INTERNATIONAL PATENT: BIONTECH SE, ONCOC4, INC. FILES APPLICATION FOR "COMBINATION THERAPY COMPRISING ANTI-CTLA4 ANTIBODIES AND CHEMOTHERAPY FOR CANCER TREATMENT"

GENEVA, March 4 -- BIONTECH SE (An der Goldgrube 1255131 Mainz), ONCOC4, INC. (9640 Medical Center DriveRockville, Maryland 20850) filed a patent application (PCT/EP2025/073984) for "COMBINATION THERAPY COMPRISING ANTI-CTLA4 ANTIBODIES AND CHEMOTHERAPY FOR CANCER TREATMENT" on Aug 22, 2025. With publication no. WO/2026/041780, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAHIN, Ugur (c/o BioNTech SEAn der Goldgrube 1255131 Mainz), WENGER, Michael Karl Maria (c/o BioNTech SEAn der Goldgrube 1255131 Mainz), TURECI, Ozlem...